Session » Spondyloarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment Poster III: Outcomes, Outcome Measures, and Comorbidities
-
Abstract Number: 2497
The Role of Individual and Country-Level Socio-Economic Factors in Work Participation in Patients with Spondyloarthritis across 22 Countries Worldwide: Results from the Comospa Study
-
Abstract Number: 2498
Rheumatologists Use Different Cut-Offs for Disease Activity in Real Life – the Experience with Golimumab in Ankylosing Spondylitis- Subanalysis from a Non-Interventional German Study
-
Abstract Number: 2499
Gender Differences in Axial and Peripheral Spondyloarthritis: Results from the Esperanza Cohort
-
Abstract Number: 2500
Are Work Outcomes Improved in Axial Spondyloarthritis (axSpA) Patients with Biologic Therapy? Results from the British Society for Rheumatology Register
-
Abstract Number: 2502
Defining Clinically Important Worsening Based on ASDAS-CRP for Axial Spondyloarthritis: A Data-Based Consensus By the Assessment in Spondyloarthritis International Society (ASAS)
-
Abstract Number: 2503
Does Maastricht Ankylosing Spondylitis Enthesitis Scores Differ between Ankylosing Spondylitis, Psoriatic Arthritis and Rheumatoid Arthritis Patients?
-
Abstract Number: 2504
The Validation of Istanbul Back Disability Index (IBDI) in Axial Spondyloarthritis Patients
-
Abstract Number: 2505
Trends in Time to Diagnosis in Spondyloarthritis Patients. Association with 2009 ASAS Classification Criteria and Clinical Presentation at Disease Onset. Data from Comospa Study
-
Abstract Number: 2506
In Ankylosing Spondylitis/Axial Spondyloarthritis Smoking Is Associated with a Dose Related Elevation in CRP, Worse Disease Activity and Worse Quality of Life over One Year
-
Abstract Number: 2507
Dactylitis and Enthesitis Predict Uveitis in Large Axial Spondyloarthropathy Cohort
-
Abstract Number: 2508
Obese Axial Spondyloarthropathy Patients Have Worse Disease Outcomes
-
Abstract Number: 2509
High Prevalence of Sarcopenia in Axial Spondyloarthropathy Cohort
-
Abstract Number: 2510
Prevalence of and Factors Associated with Sarcopenia in Patients of Ankylosing Spondylitis
-
Abstract Number: 2511
Irritable Bowel Syndrome and Its Impact on Patient-Reported Outcomes in Axial Spondyloarthritis: Is It an Overlooked Comorbidity?
-
Abstract Number: 2512
Impact of Inflammatory Bowel Disease in Early Spondyloarthritis in a Prospective Longitudinal Cohort
-
Abstract Number: 2513
The Effect of Alcohol on Disease Activity in Axial Spondyloarthritis
-
Abstract Number: 2514
When Should Lateral Dexa be Used to Measure Spine Bone Mineral Density in Axial Spondyloarthritis Patients: A Cross-Sectional Study
-
Abstract Number: 2515
Prevalence and Risk Factors for Osteoporotic Fractures and Low Bone Mineral Density in Axial Spondyloarthritis: A Systematic Review and Meta-Analysis
-
Abstract Number: 2516
Trabecular Bone Score As an Assessment Tool to Identify the Risk of Osteoporosis in Axial Spondyloarthritis: A Case-Control Study
-
Abstract Number: 2517
The Usefulness of Trabecular Bone Score in Assessing the Bone Strength and Fracture Risk of Patients with Ankylosing Spondylitis
-
Abstract Number: 2518
Racial Differences in Clinical Characteristics and Co-Morbidities of Ankylosing Spondylitis
-
Abstract Number: 2519
Characteristics of Eye Diseases in Patients with Ankylosing Spondylitis in Korea: A Single-Center Survey
-
Abstract Number: 2520
Incidence of Extra-Articular Manifestations in Psa and As Patients Treated with Golimumab in Canadian Real-World
-
Abstract Number: 2521
Metabolic Syndrome Is Associated with Active Disease in Psoriatic Arthritis and May Contribute to Development of Syndesmophytes
-
Abstract Number: 2522
Metabolic Syndrome, NAFLD and LIVER Stiffness in Psoriatic Arthritis and Psoriasis Patients: A CROSS-Sectional Study
-
Abstract Number: 2523
The Prevalence, Incidence and Associated Factors for Liver Abnormalities in Psoriatic Arthritis: Resutls from a Longitudinal Observational Cohort
-
Abstract Number: 2524
Weight Change before and after Diagnosis in Patients with Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis
-
Abstract Number: 2525
Influence of Cardiovascular Comorbidity on Achieving Therapeutic Goals: A Comparative Study between Recent-Onset Psoriatic Arthritis and Established Disease
-
Abstract Number: 2526
Baseline Data from the Recent-Onset Psoriatic Arthritis Registry of the Spanish Society of Rheumatology
-
Abstract Number: 2527
Increased Prevalence of Subclinical Atherosclerosis in Moderate-Severe Plaque Psoriasis Patients
-
Abstract Number: 2528
Prevalence of Depression and Attention Deficit Hyperactivity Disorder in Female Patients at a Combined Psoriasis-Psoriatic Arthritis Center
-
Abstract Number: 2529
Appraisal of the Contest Questionnaire in the Screening for Psoriatic Arthritis
-
Abstract Number: 2530
Clinical Specialty Setting As a Determinant for Disease Management in Patients with Psoriatic Arthritis: An Interim Analysis of the Cross-Sectional Observational Study
-
Abstract Number: 2531
Utilization of the Psoriasis Epidemiology Screening Tool to Identify Signs and Symptoms of Early Psoriatic Arthritis Among Those with Psoriasis: Analysis from the Corrona Psoriasis Registry
-
Abstract Number: 2532
The Relationship between the Degree of Skin Involvement and Joint Activity in Patients with Psa: Experience from the Corrona Registry
-
Abstract Number: 2533
Current Psa Therapy Impacts the Relationship between the Degree of Skin Invlovment and Joint Activity
-
Abstract Number: 2534
the Relationship between Biological Therapy, Work Productivity, and Activity Impairment in Patients with Psoriatic Arthritis: Prospective Multicentre Observational Study
-
Abstract Number: 2535
Patient Outcomes from a Tertiary Center Combined Rheumatology-Dermatology Clinic
-
Abstract Number: 2536
Comparison of Quality-of-Life, Function and Psoriasis Measures in Minimal Disease Activity and DAS28 States in Routine Care of Patients with Psoriatic Arthritis
-
Abstract Number: 2537
Changes in Severity, Functional Status, and Wellbeing over Time Among Individuals with Ankylosing Spondylitis (AS) in Canada: Results from the RHUMADATA® Multicentre Registry
-
Abstract Number: 2538
Change in Self-Reported Health Status and Fatigue before and after the Diagnosis of Psoriatic Arthritis- the Nord-Trondelag Health Study (HUNT)
-
Abstract Number: 2539
The Contribution of Skin and Joint Improvements to the Health-Related Quality of Life of Patients with Active Psoriatic Arthritis
-
Abstract Number: 2540
Impact of Sleep on Measures of Disease Activity in Psoriatic Arthritis
-
Abstract Number: 2541
The Relationship between the Patient Acceptable Symptom State (PASS) and Disease Activity in Patients with Psoriatic Arthritis (PsA)
-
Abstract Number: 2542
Measuring Psoriasis Specific Impact on Quality of Life: Performance of Dlqi and Skindex-17 in Early Psoriatic Arthritis
-
Abstract Number: 2543
Agreement between Paper and Pencil VAS at the Clinic and Electronic VAS at Home in Psoriatic Arthritis and Its Impact on Minimal Disease Activity
-
Abstract Number: 2544
Psoriatic Arthritis Impact of Disease (PSAID12) in Early Psoriatic Arthritis: Pain As One of the Main Determinants of Disease Impact
-
Abstract Number: 2545
Can Achieving Sustained Minimal Disease Activity (MDA) Prevent Progression of Subclinical Atherosclerosis? a Two-Year Prospective Cohort Study in Psoriatic Arthritis
-
Abstract Number: 2546
Secukinumab Decreases Arterial Wall Inflammation in Patients with Peripheral Spondyloarthritis
-
Abstract Number: 2547
the Ideal Target for Psoriatic Arthritis? Comparison of Remission and Low Disease Activity States in a Real Life Cohort
-
Abstract Number: 2548
Validation of New Potential Targets for Remission and Low Disease Activity in Psoriatic Arthritis in Patients Treated with Golimumab
-
Abstract Number: 2549
Achievement of Minimal Disease Activity Is Associated with Improvements in Health-Related Quality of Life and Productivity in Psoriatic Arthritis Patients
-
Abstract Number: 2550
A New and Simpler Tool for Global Psoriatic Arthritis Assessment: Simplified Composite Psoriatic Disease Activity Index (sCPDAI)
-
Abstract Number: 2551
Comparison between Two Cut-Off Values of Disease Activity in Psoriatic Arthritis Index and Validation of Its Simplified Clinical Version in Patients with Psoriatic Arthritis
-
Abstract Number: 2552
Inter-Connections between Fatigue, Pain and Patient Global Assessement in Patients with Active Spondyloarthritis Followed in the Daily Clinic
-
Abstract Number: 2553
Patient and Physician Global Assessment Are Poorly Inter-Connected and Poorly Explained By Other Clinical Markers of Disease Activity in Individual Patients with Psoriatic Arthritis
-
Abstract Number: 2554
Disease Activity in Psoriatic Arthritis-ESR Index Maybe a Valid Tool to Evaluate Disease Activity in Patients with Psoriatic Arthritis When CRP Is Not Available
-
Abstract Number: 2555
Clinical History of Psoriatic Arthritis over Four Decades
-
Abstract Number: 2556
Were Moll and Wright Right?